ReviewMolecular diagnosis & therapy2016

Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: An Evolving Paradigm of Molecularly Targeted Therapy.

Mohamed A M AliPubMed ↗Publisher ↗

No numbers read from the abstract.